Background: Efforts to mimic the biologic olfactory system have resulted in
the development of an electronic nose, whereby volatile gases may be ident
ified by means of organic semiconductors. Such devices have been used in th
e food and beverage industry for quality-control purposes, but to date have
not been used in the field of medicine.
Objective: To present the application of an electronic nose for clinical de
cision making by assessing the ability of an electronic nose to distinguish
cerebrospinal fluid (CSF)from serum.
Design: Randomized, prospective, masked study.
Subjects: Nineteen matched sets of CSF and serum from inpatients at a unive
rsity hospital.
Results: The electronic nose was able to distinguish CSF from serum in 18 o
f 19 patients. The data points for 18 of 19 CSF and 18 of 19 serum samples
were within statistically :distinct cluster groups, suggesting that the dev
ice is able to identify an unknown sample as CSF or serum.
Conclusions: This new technology is able to distinguish CSF from serum with
a high degree of accuracy and speed; and with small sample quantity, poten
tially allowing the physician to identify reliably CSF otorrhea or rhinorrh
ea. This revolutionary diagnostic approach may have further, widespread app
lication in the field of otorhinolaryngology and in medicine as a whole.